Live Breaking News & Updates on Oncology Early

Stay updated with breaking news from Oncology early. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

858 Therapeutics Expands Leadership Team to Support Transition to the Clinic

Katherine Bell-McGuinn, M.D., Ph.D., joins as chief medical officer Company expects to initiate a Phase I clinical trial of its PARG inhibitor ETX-19477 in 2024 SAN DIEGO (BUSINESS WIRE) 858 Therapeutics is pleased to announce today that it has named Katherine Bell-McGuinn, M.D., Ph.D., as Chief Medical. ....

United States , San Diego , Katherine Bell Mcguinn , Eli Lilly , Jeffrey Stafford , Texas Lutheran University , Memorial Sloan Kettering Cancer Center , Head Of Oncology Early Development , Johns Hopkins University School Of Medicine , Chief Medical , Vice President , Oncology Early , Johns Hopkins University School , Texas Lutheran , Versant Ventures , Cormorant Asset Management ,

Bakar Labs Awards Deciduous Therapeutics and Rubik Therapeutics 2021 Golden Tickets

/PRNewswire/ Deciduous Therapeutics and Rubik Therapeutics have won 2021 Golden Tickets, granting the companies access to free lab space and facilities for. ....

United States , Murray Robinson , Mohit Trikha , Kaspar Mossman , Berkeley Bakar Bioenginuity , Gino Segr , Robin Mansukhani , University Of California , Rosenman Institute , Head Of Oncology Early Development , Bakar Lab , Deciduous Therapeutics , Rubik Therapeutics , Bakar Labs , Bakar Bioenginuity Hub , Golden Tickets , Golden Ticket , Bakar Labs Incubator , Bakar Labs Golden Ticket , Abbvie Bay Area Site Head , Oncology Early , Woo Hon Fai , Bakar Bioenginuity , Bay Area , Allergan Aesthetics ,